Viewing Study NCT04768504


Ignite Creation Date: 2025-12-24 @ 9:19 PM
Ignite Modification Date: 2026-02-27 @ 10:33 AM
Study NCT ID: NCT04768504
Status: TERMINATED
Last Update Posted: 2024-11-25
First Post: 2021-02-20
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: Tofacitinib for the Treatment of Refractory Immune-related Colitis from Checkpoint Inhibitor Therapy- TRICK Study
Sponsor: Khashayar Esfahani
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module References Module